e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Assessment of the respiratory system
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels
F. Gomez, P. Martinez-Camblor, M. Castresana, P. Rodriguez, G. Cueto, B. R. Celli (Manacor, Palma de Mallorca, Bunyola, Spain; Boston, United States Of America)
Source:
Annual Congress 2008 - Assessment of the respiratory system
Session:
Assessment of the respiratory system
Session type:
Thematic Poster Session
Number:
955
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Gomez, P. Martinez-Camblor, M. Castresana, P. Rodriguez, G. Cueto, B. R. Celli (Manacor, Palma de Mallorca, Bunyola, Spain; Boston, United States Of America). Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels. Eur Respir J 2008; 32: Suppl. 52, 955
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF)
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010
Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Obstructive sleep apnoea does not cause elevated plasma levels of N-terminal pro-brain natriuretic peptide
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Heart rate variability, nocturnal hypoxemia and C-reactive protein in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept